Vera Therapeutics, INC. (VERA) — 8-K Filings

8-K Filings (24)

• Vera Therapeutics Announces Board and Officer Changes — Dec 18, 2025 Risk: low
  Vera Therapeutics, Inc. announced on December 16, 2025, changes in its board and officer appointments. Specifically, the company reported the departure of certa
• 8-K Filing — Dec 10, 2025
• 8-K Filing — Nov 26, 2025
• 8-K Filing — Nov 6, 2025
• Vera Therapeutics Files 8-K on Agreements — Aug 5, 2025 Risk: medium
  On August 5, 2025, Vera Therapeutics, Inc. filed an 8-K report detailing the entry into and termination of material definitive agreements. The filing also inclu
• Vera Therapeutics Enters Material Definitive Agreement — Jun 3, 2025 Risk: medium
  Vera Therapeutics, Inc. entered into a Material Definitive Agreement on June 2, 2025, which also created a direct financial obligation for the registrant. The f
• 8-K Filing — Jun 2, 2025
• Vera Therapeutics Files 8-K on Shareholder Vote Matters — May 19, 2025 Risk: low
  Vera Therapeutics, Inc. filed an 8-K on May 19, 2025, reporting on matters submitted to a vote of security holders on May 14, 2025. The filing details the compa
• Vera Therapeutics Files 8-K on Financials — May 6, 2025 Risk: low
  Vera Therapeutics, Inc. filed an 8-K on May 6, 2025, reporting on its results of operations and financial condition, as well as financial statements and exhibit
• Vera Therapeutics Files 8-K on Financials — Feb 26, 2025 Risk: low
  Vera Therapeutics, Inc. filed an 8-K on February 26, 2025, reporting on its results of operations and financial condition. The filing also includes financial st
• Vera Therapeutics Files 8-K — Jan 13, 2025 Risk: low
  Vera Therapeutics, Inc. filed an 8-K on January 13, 2025, reporting a Regulation FD Disclosure and Financial Statements and Exhibits. The filing does not contai
• Vera Therapeutics Files 8-K — Oct 31, 2024 Risk: low
  Vera Therapeutics, Inc. filed an 8-K on October 31, 2024, reporting an event that occurred on October 29, 2024. The filing is a current report pursuant to Secti
• Vera Therapeutics Files 8-K Report — Oct 28, 2024 Risk: low
  On October 26, 2024, Vera Therapeutics, Inc. filed an 8-K report. The filing indicates the company's principal executive offices are located at 8000 Marina Boul
• Vera Therapeutics Files 8-K — Oct 2, 2024 Risk: low
  On October 2, 2024, Vera Therapeutics, Inc. filed an 8-K report. The filing primarily concerns Regulation FD disclosures and financial statements and exhibits.
• Vera Therapeutics Files 8-K on Financials — Aug 8, 2024 Risk: low
  Vera Therapeutics, Inc. filed an 8-K on August 8, 2024, reporting on its results of operations and financial condition, as well as financial statements and exhi
• Vera Therapeutics Appoints New CMO, CSO, and Director — Jul 2, 2024 Risk: medium
  Vera Therapeutics, Inc. announced on June 26, 2024, the appointment of Dr. Laura Hansen as Chief Medical Officer and Dr. Jonathan Kay as Chief Scientific Office
• Vera Therapeutics Appoints New CMO, Adds Director — Jun 12, 2024 Risk: medium
  Vera Therapeutics, Inc. announced on June 7, 2024, the appointment of Dr. Michael W. Gray as Chief Medical Officer and the election of Dr. Laura J. Shaw to its
• Vera Therapeutics Files 8-K on Shareholder Vote Matters — May 17, 2024 Risk: low
  Vera Therapeutics, Inc. filed an 8-K on May 17, 2024, reporting on matters submitted to a vote of security holders on May 15, 2024. The filing details the compa
• Vera Therapeutics Files 8-K on Financials — May 9, 2024 Risk: low
  Vera Therapeutics, Inc. filed an 8-K on May 9, 2024, to report on its results of operations and financial condition, as well as to file financial statements and
• Vera Therapeutics Files 8-K on Financials — Mar 20, 2024 Risk: low
  Vera Therapeutics, Inc. filed an 8-K on March 20, 2024, reporting on its results of operations and financial condition, as well as financial statements and exhi
• Vera Therapeutics Files 8-K for 'Other Event' on Jan 29 — Jan 30, 2024
  Vera Therapeutics, Inc. filed an 8-K on January 30, 2024, reporting an 'Other Event' that occurred on January 29, 2024. This filing indicates a routine update o
• Vera Therapeutics Files 8-K on Financials & Other Events — Jan 29, 2024
  Vera Therapeutics, Inc. filed an 8-K on January 29, 2024, to report on its 'Results of Operations and Financial Condition' and 'Other Events.' This filing indic
• Vera Therapeutics Files Routine 8-K; No Material Changes Reported — Jan 25, 2024
  Vera Therapeutics, Inc. filed an 8-K on January 25, 2024, to report a routine corporate event under Regulation FD Disclosure and Other Events. This filing prima
• Vera Therapeutics Files 8-K for Reg FD Disclosure — Jan 8, 2024
  Vera Therapeutics, Inc. filed an 8-K on January 8, 2024, primarily to disclose information under Regulation FD and to file financial statements and exhibits. Th

Popular Companies

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX